Hives clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • Barzolvolimab in Participants With Chronic Spontaneous Urticaria

    open to eligible people ages 18 years and up

    The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating second generation H1-antihistamines in comparison to placebo.

    Los Angeles, California and other locations

Our lead scientists for Hives research studies include .

Last updated: